This provider's $44.2M in total Medicare payments ranks in the 98th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 41486% from 2015 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 25177% in 2022
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $22.45 | $22.00 | 1.02x | $0.45 | $53.8K | 2.4K | 3 |
| 2016 | $55.93 | $50.59 | 1.11x | $5.34 | $207.5K | 4.1K | 5 |
| 2017 | $58.02 | $46.06 | 1.26x | $11.96 | $254.8K | 5.5K | 23 |
| 2018 | $316.50 | $101.39 | 3.12x | $215.11 | $207.5K | 2.0K | 4 |
| 2019 | $581.81 | $89.86 | 6.47x | $491.95 | $91.5K | 1.0K | 3 |
| 2020 | $738.94 | $123.08 | 6.00x | $615.86 | $62.3K | 506 | 3 |
| 2021 | $690.73 | $176.31 | 3.92x | $514.42 | $82.7K | 469 | 4 |
| 2022 | $392.51 | $388.76 | 1.01x | $3.75 | $20.9M | 53.8K | 33 |
| 2023 | $291.19 | $284.18 | 1.02x | $7.01 | $22.4M | 78.7K | 59 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 8.0K | $5.3M | $668.47 | 1.01x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 7.5K | $5.0M | $668.16 | 1.01x |
| 81298 | Gene analysis (muts homolog 6 [e coli]) full sequence analysis | 6.9K | $4.4M | $633.33 | 1.01x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 5.8K | $3.5M | $592.54 | 1.01x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 5.3K | $3.1M | $592.43 | 1.01x |
| 81223 | Gene analysis (cystic fibrosis transmembrane conductance regular) full gene sequence | 5.8K | $2.8M | $492.98 | 1.01x |
| 81162 | Gene analysis (breast cancer 1 and 2) of full sequence and analysis for duplication or deletion variants | 1.1K | $2.0M | $1.8K | 1.01x |
| 81185 | Gene analysis (calcium voltage-gated channel subunit alpha1 a) of full sequence | 1.7K | $1.4M | $829.10 | 1.03x |
| 81201 | Gene analysis (adenomatous polyposis coli), full gene sequence | 1.7K | $1.3M | $766.79 | 1.02x |
| 81325 | Gene analysis (peripheral myelin protein 22), full sequence analysis | 1.7K | $1.3M | $754.19 | 1.03x |
| 81279 | Gene analysis (janus kinase 2) targeted sequence analysis | 5.8K | $1.1M | $182.98 | 1.01x |
| 81339 | Gene analysis (mpl proto-oncogene, thrombopoietin receptor) sequence analysis of exon 10 | 5.8K | $1.1M | $182.98 | 1.01x |
| 81302 | Gene analysis (methyl cpg binding protein 2) full sequence analysis | 1.9K | $961.7K | $517.31 | 1.03x |
| 81295 | Gene analysis (muts homolog 2, colon cancer, nonpolyposis type 1) full sequence analysis | 1.8K | $661.5K | $375.20 | 1.02x |
| 81300 | Gene analysis (muts homolog 6 [e coli]) duplication or deletion variants | 2.6K | $612.8K | $234.96 | 1.01x |
| 81319 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) duplication or deletion variants | 2.6K | $520.5K | $200.91 | 1.01x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 857 | $499.1K | $582.40 | 1.00x |
| 81189 | Gene analysis (cystatin b) of full sequence | 1.7K | $466.2K | $269.33 | 1.03x |
| 81286 | Gene analysis (frataxin) of full sequence | 1.7K | $447.1K | $269.33 | 1.03x |
| 81309 | Gene analysis (partner and localizer of brca2) targeted sequence analysis | 1.6K | $441.4K | $269.33 | 1.02x |
This provider submits charges 1.05 times higher than what Medicare actually pays.
A markup ratio of 1.05x means for every $100 Medicare pays, this provider initially charges $105. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in NJ for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Raritan, NJ | $1.2B | ⚠️ Flagged |
| Quest Diagnostics Incorporated | Clifton, NJ | $927.2M | ⚠️ Flagged |
| Bioreference Health, Llc | Elmwood Park, NJ | $841.0M | ⚠️ Flagged |
| Accu Reference Medical Lab, Llc | Linden, NJ | $204.9M | ⚠️ Flagged |
| Aculabs Inc | East Brunswick, NJ | $91.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data